Botulism immune globulin

Drug Profile

Botulism immune globulin

Alternative Names: BabyBIG; BIG-IV; Botulinum toxin immune globulin; Botulism immune globulin intravenous (human); Botulism IVIG; Human-derived botulinum antitoxin; IV botulism immune globulin

Latest Information Update: 06 Apr 2004

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator California Department of Health Services
  • Class Immunoglobulins
  • Mechanism of Action Botulinum toxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Botulism

Highest Development Phases

  • Marketed Botulism

Most Recent Events

  • 31 Dec 2003 Launched for Botulism in USA (IV)
  • 23 Oct 2003 Registered for Botulism in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top